Primary emergencies; management of acute ischemic stroke;Urgences primaires : Prise en charge des urgences vasculaires cérébrales ischémiques

Bulletin de l'Academie Nationale de Medecine

Volumn 196, Issue 4-5, 2012, Pages 909-925

  Leys, Didier ^a   Goldstein, Patrick ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Emergency medicine; Ischemia; Pituitary apoplexy; Stoke

Indexed keywords

EID: 84874919626     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)31779-0     Document Type: Article

References (44)

1. Hankey G.J., Warlow C.P.- Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet, 1999, 354, 1457-1463. (Pubitemid 29494766)
2. Murray C.J., Lopez A.D. - Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet, 1997, 349, 1436-1442. (Pubitemid 27212192)
3. Leys D., Ringelstein E.B., Kaste M., Hacke W. - Facilities available in European hospitals treating stroke patients. Stroke. 2007, 38, 2985-2991. (Pubitemid 350035694)
4. Hacke W., Donnan G., Fieschi C. et al. - Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004, 363, 768-774.
5. Hacke W., Kaste M., Bluhmki E. et al. - Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med., 2008, 359, 1317-1329.
6. The national institute of neurological disorders and stroke RT-PA Stroke study group - Tissue plasminogen activator for acute ischemic stroke. New Engl. J. Med., 1995, 333, 1581-1587.
7. Hacke W., Kaste M., Fieschi C. et al. - Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Stroke. JAMA, 1995, 274, 1017-1025.
8. Hacke W., Kaste M., Fieschi C. et al. - Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet, 1998, 352, 1245-1251. (Pubitemid 28470336)
9. Clark W.M., Wissman S., Albers G.W. et al. - Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999, 282, 2019-2026.
10. Clark W.M., Albers G.W., Madden k.P., Hamilton S. - The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke, 2000, 31, 811-816. (Pubitemid 30198420)
11. Lansberg M.G., Schrooten M., Bluhmki E. et al. -Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke, 2009, 40, 2079-2084.
12. Lees K.R., Bluhmki E., Von Kummer R. etal. -Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet, 2010, 375, 1695-1703.
13. Davis S.M., Donnan G.A., Parsons M. W. et al. - Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol., 2008, 7, 299-309.
14. Wahlgren N., Ahmed N., Davalos A. et al. - Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet, 2007, 369, 275-282. (Pubitemid 46138121)
15. Wahlgren N., Ahmed N., Davalos A. et al. - Thrombolysis with alteplase 3-4.5 h after acutc ischaemic stroke (SITS-ISTR): an observational study. Lancet, 2008, 372, 1303-1309.
16. The European stroke organisation (ESO) executive committee - Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis., 2008, 25, 457-507. (updated at: http://www.eso-stroke.org/ pdf/ESO%420Guidelines-updatc-Jan-2009.pdf).
17. Hill M.D., Buchan A.M. - Thrombolysis for acutc ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study (CASES). CMAJ. 2005, 172, 1307-1312. (Pubitemid 40745072)
18. Engelter S.T., Reichhart M., Sekoranja L. et al. - Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology, 2005, 65, 1795-1798.
19. Engelter S.T., Dallongeville J., Kloss M. et al. - Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur. J. Neurol 2012, 19, 1199-1206.
20. Engelter S.T., Rutgers M P., Hatz F. et al. - Intravenous thrombolysis in stroke attributable to cervical artery dissection. Stroke. 2009, 40, 3772-3776.
21. Sarikaya H., Arnold M., Engelter S.T. etal. - Intravenous thrombolysis in nonagenarians with ischemic stroke. Stroke, 42, 1967-1970.
22. Strbian D., Meretoja A., Ahlhelm F.J. et al. - Predicting outcome of IV thrombolysis- treated ischemic stroke patients: the DRAGON score. Neurology, 78, 427-432.
23. Zinkstok S.M., Vergouwen M.D., Engelter S.T. et al. - Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data. Stroke, 42, 2515-2520.
24. Paciaroni M., Balucani C., Agnelli G. et al. - Systemic Thrombolysis in Patients With Acute Ischemic Stroke and Internal Carotid ARtery Occlusion: The ICARO Study. Stroke, 2012, 43, 125-130.
25. Schellinger P.D., Thomalla G., Fiehler J. et al. - MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke, 2007, 38, 2640-2645. (Pubitemid 47493997)
26. Mazighi M., Serfaty J.M., Labreuche J. et al. - Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANAL1SE study): a prospective cohort study. Lancet Neurol., 2009, 8, 802-809.
27. Parsons M., Spratt N., Bibard A. et al. - A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N. Engl. J. Med., 366, 1099-1107.
28. Cast-collaborative-group- CAST : randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischeaemic stroke. The Lancet. 1997, 349, 1641-1649.
29. International-stroke-trial-collaborative-group - The International Stroke Trial (IST): a randomised trial if aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet, 1997, 349, 1569-1581.
30. Hankey G.J., Johnston S.C., Easton J.D. et al. - Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int. J. Stroke, 2011, 6, 3-9.
31. Bath P.M., Iddenden R., Bath F.J. - Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke. 2000, 31, 1770-1778. (Pubitemid 30437536)
32. Vahedi K., Hofmeijer J., Juttler E. et al. - Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol., 2007, 6, 215-222. (Pubitemid 46237760)
33. Baron J.C. - Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc. Dis.. 2001, II Suppl. I, 2-8.
34. Stroke unit trialists'collaboration - Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev., 2002, CD000197.
35. Indredavik B., Bakke F., Slordahl S.A. et al. - Stroke unit treatment. 10-year follow-up. Stroke. 1999, 30, 1524-1527. (Pubitemid 29379596)
36. Derex L., Adelaine P., Nighoghossian N. et al. - Factors influencing early admission in a French stroke unit. Stroke, 2002, 33, 153-159. (Pubitemid 34052203)
37. Mehdiratta M., Woolfenden A., Chapman K. et al. - Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can. J. Neurol. Sci., 2006, 33, 214-216. (Pubitemid 43845177)
38. Kim Y.S., Park S.S., Bae H.J. et al. - Stroke awareness decreases prehospital delay after acute ischemic stroke in Korea. BMC Neurol., 2011, 11, 2.
39. Patel M.D., Rose KM., O'Brien E.C., Rosamond W.D. - Prehospital notification by emergency medical services reduces delays in stroke evaluation: findings from the North Carolina stroke care collaborative. Stroke. 2011, 42, 2263-2268.
40. Evenson K.R., Foraker R.E., Morris D.L., Rosamond W.D. - A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int. J. Stroke. 2009, 4, 187-199.
41. Stemo Consortium. - Phantom-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients - study. Int. J. Stroke, 2012.
42. Schellinger P.D., Chalela J.A., Kang D.W. et al. - Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am. J. Neuroradiol., 2005, 26, 618-624. (Pubitemid 43085968)
43. Schellinger P.D., Fiebach J.B., Jansen O. et al. - Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann. Neurol 2001, 49, 460-469.
44. Moulin T., Cattin F., Crepin-Leblond T. et al. - Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology. 1996, 47, 366-375. (Pubitemid 26324029)